Search Results - Getsy, Jay

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    A Phase I Study to Investigate the Absorption, Pharmacokinetics, and Excretion of [14 C]Prucalopride After a Single Oral Dose in Healthy Volunteers

    A Phase I Study to Investigate the Absorption, Pharmacokinetics, and Excretion of [14 C]Prucalopride After a Single Oral Dose in Healthy Volunteers by Flach, Stephen, MD, PhD, Scarfe, Graeme, PhD, Dragone, Jeffrey, MS, Ding, Jie, PhD, Seymour, Mark, PhD, Pennick, Mike, BSc, Pankratz, Todd, MS, MBA, Troy, Steven, MS, Getsy, Jay, DMD, DO

    Published in Clinical therapeutics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Pharmacokinetics, absorption, and excretion of radiolabeled revexepride: a Phase I clinical trial using a microtracer and accelerator mass spectrometry-based approach

    Pharmacokinetics, absorption, and excretion of radiolabeled revexepride: a Phase I clinical trial using a microtracer and accelerator mass spectrometry-based approach by Flach, Stephen, Croft, Marie, Ding, Jie, Budhram, Ron, Pankratz, Todd, Pennick, Mike, Scarfe, Graeme, Troy, Steven, Getsy, Jay

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Pharmacokinetic Interactions between Sirolimus and Microemulsion Cyclosporine When Orally Administered Jointly and 4 Hours Apart in Healthy Volunteers

    Pharmacokinetic Interactions between Sirolimus and Microemulsion Cyclosporine When Orally Administered Jointly and 4 Hours Apart in Healthy Volunteers by Zimmerman, James J., Harper, Dawn, Getsy, Jay, Jusko, William J.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Pharmacokinetics of Zilurgisertib With and Without Food from Single and Multiple Ascending Dose Phase 1 Studies in Healthy Adults

    Pharmacokinetics of Zilurgisertib With and Without Food from Single and Multiple Ascending Dose Phase 1 Studies in Healthy Adults by Yang, Yan-Ou, Gong, Xiaohua, Getsy, Jay, Wang, Phillip, Liu, Xiang, Sheng, Jennifer, Chen, Xuejun, Rockich, Kevin

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    Abstract CT243: Clinical trial simulation to inform dose selection of zilurgisertib, an ALK2 inhibitor, in patients with anemia due to myelofibrosis (MF)

    Abstract CT243: Clinical trial simulation to inform dose selection of zilurgisertib, an ALK2 inhibitor, in patients with anemia due to myelofibrosis (MF) by Yang, Yan-ou, Yang, Hong, Lamothe, Betty, Stubbs, Matthew, McBride, Amanda, Seguy, Francis, Rockich, Kevin, Getsy, Jay, Wang, Phillip, Liu, Xiang, Jackson, Jeff, Asatiani, Ekaterine, Chen, Xuejun

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Molecular, Biologic, and Pharmacokinetic Properties of Monoclonal Antibodies: Impact of These Parameters on Early Clinical Development

    Molecular, Biologic, and Pharmacokinetic Properties of Monoclonal Antibodies: Impact of These Parameters on Early Clinical Development by Mascelli, Mary Ann, Zhou, Honghui, Sweet, Raymond, Getsy, Jay, Davis, Hugh M., Graham, Martin, Abernethy, Darrell

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: